Filing Details
- Accession Number:
- 0001384101-19-000170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-31 16:09:00
- Reporting Period:
- 2019-12-27
- Accepted Time:
- 2019-12-31 16:09:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1543503 | Keith Kennedy | 6000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Coo / Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-27 | 400 | $7.47 | 110,103 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-12-27 | 400 | $30.00 | 109,703 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-12-27 | 400 | $0.00 | 400 | $7.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
51,442 | 2026-12-05 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.
- Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.02. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option began to vest on December 6, 2017 and vests at a rate of 1/36th of the total number of shares subject to the award each month, subject to the continuing employment of the reporting person on each vesting date.